+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

LeMaitre Vascular Inc (LMAT) - Product Pipeline Analysis, 2025 Update

LeMaitre Vascular Inc (LeMaitre Vascular) provides medical devices and services for the treatment of peripheral vascular diseases. The company develops, manufactures, and markets disposable and implantable devices that vascular surgeons use in arteries and veins outside the heart in open vascular surgeries and minimally invasive procedures. Its product portfolio includes polycarbonate grafts, balloon catheters, carotid shunts, radiopaque tapes, powered phlebectomy devices, valvulotomes, remote endarterectomy devices, vascular grafts, patches, contrast injector, ePTFE grafts, and closure systems. It also offers angioscopes and human tissue cryopreservation services. LeMaitre Vascular sells its products through direct sales force and subsidiaries in North America, Europe, Asia-Pacific and through distributors in other geographies. LeMaitre Vascular is headquartered in Burlington, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company LeMaitre Vascular Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.

Reasons to Buy:

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

  • LeMaitre Vascular Inc Company Overview
  • LeMaitre Vascular Inc Company Snapshot
  • LeMaitre Vascular Inc Pipeline Products and Ongoing Clinical Trials Overview
  • LeMaitre Vascular Inc - Pipeline Analysis Overview
  • Business Description
  • LeMaitre Vascular Inc - Key Facts
  • LeMaitre Vascular Inc - Major Products and Services
  • LeMaitre Vascular Inc Pipeline Products by Development Stage
  • LeMaitre Vascular Inc Ongoing Clinical Trials by Trial Status
  • LeMaitre Vascular Inc Pipeline Products Overview
  • CardioCel Neo
  • CardioCel Neo Product Overview
  • CardioCel Neo Clinical Trial
  • Elongated AnastoClip AC
  • Elongated AnastoClip AC Product Overview
  • Elongated AnastoClip GC
  • Elongated AnastoClip GC Product Overview
  • LeMaitre Valvulotome
  • LeMaitre Valvulotome Product Overview
  • PIOC Occlusion Catheter
  • PIOC Occlusion Catheter Product Overview
  • LeMaitre Vascular Inc - Key Competitors
  • LeMaitre Vascular Inc - Key Employees
  • LeMaitre Vascular Inc - Key Employee Biographies
  • LeMaitre Vascular Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Recent Developments
  • LeMaitre Vascular Inc, Recent Developments
  • Apr 07, 2025: LeMaitre Will Announce First Quarter 2025 Earnings Results May 1, 2025
  • Apr 01, 2025: LeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conference
  • Oct 31, 2024: LeMaitre Reports Q3 2024 Results
  • Oct 17, 2022: LeMaitre Will Announce Third Quarter 2022 Earnings Results October 27, 2022
  • Aug 31, 2022: LeMaitre to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
  • Jul 18, 2022: LeMaitre Will Announce Second Quarter 2022 Earnings Results July 28, 2022
  • Apr 15, 2022: LeMaitre Will Announce First Quarter 2022 Earnings Results April 28, 2022
  • Apr 07, 2022: LeMaitre Vascular receives 510(k) clearance for PhasTIPP
  • Feb 11, 2022: LeMaitre Will Announce Fourth Quarter 2021 Earnings Results February 24, 2022
  • Oct 14, 2021: LeMaitre Will Announce Third Quarter 2021 Earnings Results on October 28, 2021
  • Appendix
  • Methodology
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • LeMaitre Vascular Inc Pipeline Products and Ongoing Clinical Trials Overview
  • LeMaitre Vascular Inc Pipeline Products by Equipment Type
  • LeMaitre Vascular Inc Pipeline Products by Indication
  • LeMaitre Vascular Inc Ongoing Clinical Trials by Trial Status
  • LeMaitre Vascular Inc, Key Facts
  • LeMaitre Vascular Inc, Major Products and Services
  • LeMaitre Vascular Inc Number of Pipeline Products by Development Stage
  • LeMaitre Vascular Inc Pipeline Products Summary by Development Stage
  • LeMaitre Vascular Inc Ongoing Clinical Trials by Trial Status
  • LeMaitre Vascular Inc Ongoing Clinical Trials Summary
  • CardioCel Neo - Product Status
  • CardioCel Neo - Product Description
  • CardioCel Neo - Post-market Registry in Europe for the Use of CardioCel, CardioCel Neo and CardioCel 3D
  • Elongated AnastoClip AC - Product Status
  • Elongated AnastoClip AC - Product Description
  • Elongated AnastoClip GC - Product Status
  • Elongated AnastoClip GC - Product Description
  • LeMaitre Valvulotome - Product Status
  • LeMaitre Valvulotome - Product Description
  • PIOC Occlusion Catheter - Product Status
  • PIOC Occlusion Catheter - Product Description
  • LeMaitre Vascular Inc, Key Employees
  • LeMaitre Vascular Inc, Key Employee Biographies
  • LeMaitre Vascular Inc, Other Locations
  • LeMaitre Vascular Inc, Subsidiaries
  • Glossary
List of Figures
  • LeMaitre Vascular Inc Pipeline Products by Equipment Type
  • LeMaitre Vascular Inc Pipeline Products by Development Stage
  • LeMaitre Vascular Inc Ongoing Clinical Trials by Trial Status

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Boston Scientific Corp
  • Baxter International Inc
  • Medtronic Vascular Inc
  • Getinge AB
  • Terumo Medical Corp
  • LifeNet Health Inc
  • Artivion Inc
  • Edwards Lifesciences Corp
  • W. L. Gore & Associates Inc
  • Cardiovascular Systems Inc
  • Becton Dickinson and Co